Charles S. Bestwick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Charles S. Bestwick has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ajay Iyer
Conway Institute of Biomolecular Research, University College Dublin, Belfield, Ireland
2 shared publications - Sylvia H. Duncan
Rowett Institute, University of Aberdeen
2 shared publications - Wendy Russell
Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
2 shared publications - Eva C. Soto-Martín
University of Aberdeen Institute of Medical Sciences
1 shared publication - Gary Cameron
Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen
1 shared publication - Gary J. Duncan
University of Aberdeen, Rowett Institute
1 shared publication
Latest Publications
- Open Access
Simulated digestion, uptake and colonic fermentation of Gorse ( Ulex europeaus ) suggests safe use as a source of protein concentrates and bioactives
Background: Invasive plants such as Gorse ( Ulex europeaus ) may serve as a potentially sustainable source of edible proteins and bioactives through the production of leaf protein concentrates (GLPC). The digestion, uptake and safety of phytochemicals from GLPC and the protein depleted but bioactive rich fraction (PDF) from Gorse was studied using an in vitro simulated digestion model. Results: Both the Gorse fractions and their digesta maintained the viability of cultured (Caco-2) intestinal cells above the 80% threshold, suggesting a lack of overt toxicity. In the digestion model, most of the plant metabolites in the digesta were largely confined to the apical fraction of the Caco-2 monolayer (representing the lumen) and were subsequently expected to be delivered to the colon. Food matrix had a significant but marginal effect on the permeability of metabolites across the Caco-2 monolayer. Lastly, in vitro intestinal microbial action appeared to produce beneficial compounds such as enterolactones, and equol. Conclusion: The Gorse fractions lack general overt toxicity to Caco-2 cells. GLPC and PDF provide metabolic substrates for the colonic microbes to produce secondary compounds that are associated with positive health outcomes.
Open AccessSimulated digestion, uptake and colonic fermentation of Gorse ( Ulex europeaus ) suggests safe use as a source of protein concentrates and bioactives
Background: Invasive plants such as Gorse ( Ulex europeaus ) may serve as a potentially sustainable source of edible proteins and bioactives through the production of leaf protein concentrates (GLPC). The digestion, uptake and safety of phytochemicals from GLPC and the protein depleted but bioactive rich fraction (PDF) from Gorse was studied using an in vitro simulated digestion model. Results: Both the Gorse fractions and their digesta maintained the viability of cultured (Caco-2) intestinal cells above the 80% threshold, suggesting a lack of overt toxicity. In the digestion model, most of the plant metabolites in the digesta were largely confined to the apical fraction of the Caco-2 monolayer (representing the lumen) and were subsequently expected to be delivered to the colon. Food matrix had a significant but marginal effect on the permeability of metabolites across the Caco-2 monolayer. Lastly, in vitro intestinal microbial action appeared to produce beneficial compounds such as enterolactones, and equol. Conclusion: The Gorse fractions lack general overt toxicity to Caco-2 cells. GLPC and PDF provide metabolic substrates for the colonic microbes to produce secondary compounds that are associated with positive health outcomes.
- Open Access
Gorse ( Ulex europeaus ) wastes with 5,6-dimethyl benzimidazole supplementation can support growth of vitamin B 12 producing commensal gut microbes
Many commensal gut microbes are recognized for their potential to synthesize vitamin B 12 , offering a promising avenue to address deficiencies through probiotic supplementation. While bioinformatics tools aid in predicting B 12 biosynthetic potential, empirical validation remains crucial to confirm production, identify cobalamin vitamers, and establish biosynthetic yields. This study investigates vitamin B 12 production in three human colonic bacterial species: Anaerobu-tyricum hallii DSM 3353, Roseburia faecis DSM 16840, and Anaerostipes caccae DSM 14662, along with Propionibacterium freudenreichii DSM 4902 as a positive control. These strains were selected for their potential use as probiotics, based on speculated B 12 production from prior bioinformatic analyses. Cultures were grown in M2GSC, chemically defined media (CDM), and Gorse extract medium (GEM). The composition of GEM was similar to CDM, expect that the carbon and nitrogen source was replaced with protein-depleted liquid wastes obtained after subjecting Gorse to a leaf protein extraction process. B 12 yields were quantified using liquid chromatography with tandem mass spectrophotometry. The results suggest that the three butyrate-producing strains could indeed produce B 12 , although the yields were notably low, and with no B 12 being detected in the extracellular media. Next, GEM outperformed the conventional M2GSC growth medium in enhancing B 12 production. The positive control, P. freudenreichii DSM 4902 produced B 12 at concentrations ranging from 7 ng·mL −1 to 12 ng·mL −1 . Univariate-scaled Principal Component Analysis of data from previous publications investigating B 12 production in P. freudenreichii revealed that B 12 yields diminished when the carbon source concentration was ≤ 30 g·L −1 . In conclusion, the protein-depleted wastes from the leaf protein extraction process from Gorse can be valorised as a viable substrate for culturing B 12 -producing colonic gut microbes. Furthermore, this is the first report attesting to the ability of A. hallii, R. faecis , and A. caccae to produce B 12 . However, these microbes seem unsuitable for industrial applications owing to low B 12 yields.
Open AccessGorse ( Ulex europeaus ) wastes with 5,6-dimethyl benzimidazole supplementation can support growth of vitamin B 12 producing commensal gut microbes
Many commensal gut microbes are recognized for their potential to synthesize vitamin B 12 , offering a promising avenue to address deficiencies through probiotic supplementation. While bioinformatics tools aid in predicting B 12 biosynthetic potential, empirical validation remains crucial to confirm production, identify cobalamin vitamers, and establish biosynthetic yields. This study investigates vitamin B 12 production in three human colonic bacterial species: Anaerobu-tyricum hallii DSM 3353, Roseburia faecis DSM 16840, and Anaerostipes caccae DSM 14662, along with Propionibacterium freudenreichii DSM 4902 as a positive control. These strains were selected for their potential use as probiotics, based on speculated B 12 production from prior bioinformatic analyses. Cultures were grown in M2GSC, chemically defined media (CDM), and Gorse extract medium (GEM). The composition of GEM was similar to CDM, expect that the carbon and nitrogen source was replaced with protein-depleted liquid wastes obtained after subjecting Gorse to a leaf protein extraction process. B 12 yields were quantified using liquid chromatography with tandem mass spectrophotometry. The results suggest that the three butyrate-producing strains could indeed produce B 12 , although the yields were notably low, and with no B 12 being detected in the extracellular media. Next, GEM outperformed the conventional M2GSC growth medium in enhancing B 12 production. The positive control, P. freudenreichii DSM 4902 produced B 12 at concentrations ranging from 7 ng·mL −1 to 12 ng·mL −1 . Univariate-scaled Principal Component Analysis of data from previous publications investigating B 12 production in P. freudenreichii revealed that B 12 yields diminished when the carbon source concentration was ≤ 30 g·L −1 . In conclusion, the protein-depleted wastes from the leaf protein extraction process from Gorse can be valorised as a viable substrate for culturing B 12 -producing colonic gut microbes. Furthermore, this is the first report attesting to the ability of A. hallii, R. faecis , and A. caccae to produce B 12 . However, these microbes seem unsuitable for industrial applications owing to low B 12 yields.